Natural product-derived Life-extension therapy: Cryptotanshinone (CPT), found in Salvia miltiorrhiza Bunge, inhibits the expression of Ribosomal protein S6 kinase 1 (p70S6 Kinase) and extends mammalian life span, 29/March/2017, 7.54 am

Natural product-derived PD-1 pathway blockade for Human cancer therapy: Salvianolic acid A, one of the main components of Salvia Miltiorrhiza Bge, decreases the activity of Glycogen synthase kinase-3β, increases transcription factor T-bet expression, decreases the abundance of co-inhibitory receptor PD-1 on the cell surface of Cytotoxic-T-cells, increases cytotoxic T lymphocyte function and augments anti-tumor activity, via up-regulation of its target gene, 29/March/2017,4.53 am
March 28, 2017
Natural product-derived therapy for Myocardial Infarction: Salvianolic acid B, isolated from Salvia Miltiorrhiza Bge, inhibits DNA damage responses, induces telomerase expression, inhibits telomere shortening, and promotes cardiomyocyte survival after myocardial infarction via up regulation of PNUTS, 29/March/2017, 11.11 am
March 29, 2017
Show all

What they say:

A study from the Institute of Healthy Ageing, Centre for Diabetes and Endocrinology, Department of Medicine, University College London, London WC1E 6JJ, UK shows that “Ribosomal protein S6 kinase 1 signaling regulates mammalian life span.” This study was published in the 2 October 2009 issue of the Journal “Science” (I.F: 31.477 ) by Prof Dominic J. Withers, Dr. Selman C and others.


What we say

On the foundation of this interesting finding, Dr L Boominathan PhD, Director-cum-chief Scientist of GBMDreports, for the first time, that: Natural product-derived Life-extension therapy: Cryptotanshinone (CPT), found in Salvia miltiorrhiza Bunge, inhibits the expression of Ribosomal protein S6 kinase 1 (p70S6 Kinase) and extends mammalian life span


Research findings to Therapeutic opportunity: 

Criptoshinone inhibits p70 S6 kinase and promotes longevity

Figure 1. Mechanistic insight into how Cryptotanshinone (CPT) may extend lifespan. Cryptotanshinone (CPT) may promote longevity by suppressing the expression of p70 S6 kInase

Cryptotanshinone (CPT), by  increasing  the expression of its target gene, it may suppress Ribosomal protein S6 kinase 1 (p70S6 Kinase) expression. Thereby, it may promote: (1) resistance to bone, immune, and motor dysfunction; (2) insulin sensitivity; and (3) longevity (fig. 1).   

[easy_payment currency=”USD”]

Thus, pharmacological formulations encompassing Cryptotanshinone (CPT) or its analogs either alone or in combination with any of the known longevity-promoting compound(s) may be used to extend the lifespan of an individual (fig. 1).


Details of the research findings: 

Idea Proposed/Formulated (with experimental evidence) by:

Dr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

Undisclosed mechanistic Information: How  Cryptotanshinone (CPT) decreases p70 S6 Kinase expression and promotes mammalian life span

# Research cooperation

Amount: $50#

For purchase and payment information, you may reach us at info@genomediscovery.org


References:

CitationBoominathan, L.,    Natural product-derived Life-extension therapy: Cryptotanshinone (CPT), found in Salvia miltiorrhiza Bunge, inhibits the expression of Ribosomal protein S6 kinase 1 (p70S6 Kinase) and extends mammalian life span, 29/March/2017, 7.54 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Web: http://genomediscovery.org or newbioideas.com/

Courtesy: When you cite drop us a line at info@genomediscovery.org

Comments are closed.